← Back to headlines
FDA Approves Gilead’s Once-Daily Combination Pill for HIV Treatment
The U.S. Food and Drug Administration has approved Gilead Sciences’ new once-daily combination medication for treating HIV infection. The approval aims to simplify long-term antiretroviral therapy and improve patient adherence.
27 Aug, 21:49 — 27 Aug, 22:02
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left2
Left (2)
Yahoocnbc
Center
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual1d ago
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
Read full article →YahooMostly Factual1d ago
US FDA approves Gilead's once-daily combination pill for HIV treatment
Read full article →Coverage Timeline
First report: cnbc · 27 Aug, 21:49|Full coverage: 2 · 13m|Window: 13m
Left-leaningCenterRight-leaning
